CSIMarket
 


Lexaria Bioscience Corp   (LXRP)
Other Ticker:  
 
 

LXRP's Revenue Growth by Quarter and Year

Lexaria Bioscience 's Revenue results by quarter and year




LXRP Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter August - 0.13 0.10 0.94
III Quarter May 0.09 0.06 0.14 0.03
II Quarter February 0.11 0.02 0.17 0.01
I Quarter November 0.06 0.02 0.02 0.28
FY   0.26 0.23 0.43 1.26



LXRP Revenue third quarter 2020 Y/Y Growth Comment
Lexaria Bioscience Corp achieved in the third quarter, above Company average Revenue rise of 49.44% year on year, to $ 0.09 millions.

According to the results reported in the third quarter, Lexaria Bioscience Corp achieved the best Revenue growth in Legal Marijuana industry. While Lexaria Bioscience Corp ' s Revenue jump of 49.44% ranks overall at the positon no. 1 in the third quarter.




LXRP Revenue ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter August - 30 % -89.36 % 147.37 %
III Quarter May 49.44 % -57.14 % 366.67 % -76.92 %
II Quarter February 450 % -88.24 % 1600 % -92.31 %
I Quarter November 200 % 0 % -92.86 % 2700 %
FY   - -46.51 % -65.87 % 93.85 %

Financial Statements
Lexaria Bioscience 's third quarter 2020 Revenue $ 0.09 millions LXRP's Income Statement
Lexaria Bioscience 's third quarter 2019 Revenue $ 0.06 millions Quarterly LXRP's Income Statement
New: More LXRP's historic Revenue Growth >>


LXRP Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter August - 116.67 % -28.57 % 3033.33 %
III Quarter May -18.49 % 200 % -17.65 % 200 %
II Quarter February 83.33 % 0 % 750 % -96.43 %
I Quarter November -53.85 % -80 % -97.87 % -26.32 %
FY (Year on Year)   - -46.51 % -65.87 % 93.85 %




Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Legal Marijuana Industry #1
Consumer Non Cyclical Sector #1
Overall #1

Revenue Y/Y Growth Statistics
High Average Low
79.56 % -2.96 % -66.08 %
(Aug 31 2017)   (Aug 31 2018)
Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Legal Marijuana Industry #1
Consumer Non Cyclical Sector #1
Overall #1
Revenue Y/Y Growth Statistics
High Average Low
79.56 % -2.96 % -66.08 %
(Aug 31 2017)   (Aug 31 2018)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Lexaria Bioscience 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
3114.59 % 178.13 % -98.5 %
(Aug 31 2017)   (Nov 30 2015)


LXRP's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2020 Lexaria Bioscience Corp realized fall in Revenue from the previous quarter by -18.49% to $ 0.09 millions, from $ 0.11 millions released a quarter before.

Although cyclical factors usually fuel III. Quarter 2020 results, this plainly was not substantial to recover Legal Marijuana's company III. Quarter outcome, Grace  Wood, Legal Marijuana industry expert pointed out.

Within Legal Marijuana industry Lexaria Bioscience Corp achieved highest sequential Revenue growth. While Lexaria Bioscience 's Revenue growth quarter on quarter, overall rank is 24.


Revenue Q/Q Growth Company Ranking
Within: No.
Legal Marijuana Industry #1
Consumer Non Cyclical Sector #5
Overall #24
Revenue Q/Q Growth Company Ranking
Within: No.
Legal Marijuana Industry #1
Consumer Non Cyclical Sector #5
Overall #24
Revenue Q/Q Growth Statistics
High Average Low
3114.59 % 178.13 % -98.5 %
(Aug 31 2017)   (Nov 30 2015)


LXRP's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2020 Lexaria Bioscience Corp disclosed fall in Revenue sequentially by -18.49% to $ 0.09 millions, from $ 0.11 millions declared in the previous reporting period.

Some cyclical influence were not able to salvage the III. Quarter for the Lexaria Bioscience Corp , Grace  Wood, Legal Marijuana industry expert said, she voiced little caution conserning Lexaria Bioscience 's outlook, she identified new headwinds ahead for Lexaria Bioscience .

Within Legal Marijuana industry Lexaria Bioscience Corp achieved highest sequential Revenue growth. While Lexaria Bioscience 's Revenue growth quarter on quarter, overall rank is 24.


Lexaria Bioscience 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(May 31 2020)
12 Months Ending
(Feb 29 2020)
12 Months Ending
(Nov 30 2019)
12 Months Ending
(Aug 31 2019)
12 Months Ending
(May 31 2019)
Cumulative Revenue 12 Months Ending $ 0.39 $ 0.36 $ 0.27 $ 0.23 $ 0.19
Y / Y Revenue Growth (TTM) 101.89 % 31.86 % -37.41 % -46.97 % -84.82 %
Year on Year Revenue Growth Overall Ranking # 1 # 7 # 380 # 2955 # 3585
Seqeuential Revenue Change (TTM) 8.22 % 34.1 % 17.35 % 18.55 % -29.32 %
Seq. Revenue Growth (TTM) Overall Ranking # 1 # 7 # 3 # 175 # 3547




Cumulative Revenue growth Comment
With 101.89% annual Revenue growth, Lexaria Bioscience Corp would report a record annual Revenue surge if the fiscal year would end on May 31 2020.

Lexaria Bioscience Corp achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 1, from total ranking in previous quarter at 7.

Revenue TTM Q/Q Growth Statistics
High Average Low
79.56 %
-2.96 %
-66.08 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Marijuana Industry # 1
Consumer Non Cyclical Sector # 1
Overall # 1

Revenue TTM Y/Y Growth Statistics
High Average Low
101.89 %
-10.84 %
-84.82 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 1
S&P 500 # 1
Cumulative Revenue growth Comment
With 101.89% annual Revenue growth, Lexaria Bioscience Corp would report a record annual Revenue surge if the fiscal year would end on May 31 2020.

Lexaria Bioscience Corp achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 1, from total ranking in previous quarter at 7.

Revenue TTM Q/Q Growth Statistics
High Average Low
79.56 %
-2.96 %
-66.08 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Marijuana Industry # 1
Consumer Non Cyclical Sector # 1
Overall # 1

Revenue TTM Y/Y Growth Statistics
High Average Low
101.89 %
-10.84 %
-84.82 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 1
S&P 500 # 1




Other Revenue Growth
Legal Marijuana Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LXRP's Revenue Growth Ratio versus Legal Marijuana Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for LXRP's Competitors
Revenue Growth for Lexaria Bioscience 's Suppliers
Revenue Growth for LXRP's Customers

You may also want to know
LXRP's Annual Growth Rates LXRP's Profitability Ratios LXRP's Asset Turnover Ratio LXRP's Dividend Growth
LXRP's Roe LXRP's Valuation Ratios LXRP's Financial Strength Ratios LXRP's Dividend Payout Ratio
LXRP's Roa LXRP's Inventory Turnover Ratio LXRP's Growth Rates LXRP's Dividend Comparisons



Companies with similar Revenue surge for the quarter ending May 31 2020 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending May 31 2020
Lexaria Bioscience Corp   49.61 %$ 49.610 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ITUS's Profile

Stock Price

ITUS's Financials

Business Description

Fundamentals

Charts & Quotes

ITUS's News

Suppliers

ITUS's Competitors

Customers & Markets

Economic Indicators

ITUS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071